Rick Maffei

A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.

The US FDA has granted Priority Review to ofatumumab used in combination with fludarabine and cyclophosphamide for the treatment of chronic lymphocytic leukemia.

A study examined the relation between various forms of breast cancer therapies and risk of congestive heart failure.

For patients with stage I to III HER2-positive breast cancer, the monoclonal antibody trastuzumab is central to their adjuvant therapy.

Nearly 50% of patients with stage II/III rectal cancer achieve a complete clinical response via neoadjuvant chemoradiation.

A new study indicates that patient travel distance to an appropriate treatment facility can impact whether radiation therapy is received.

A recent study examined the risk of cardiovascular disease for the survivors of adolescent and young adult cancer.

A study examined the relationship between depression and survival for patients undergoing hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery.

Darbepoetin alfa reduced the incidence of red blood cell transfusions in anemic patients with low and intermediate-1 risk myelodysplastic syndrome, according to phase 3 clinical trial data.

A majority of Americans polled support Vice President Joe Biden’s ‘moonshot’ initiative.